Department of Obstetrics and Gynecology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Department of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, 200092, China.
Cancer Lett. 2020 Mar 31;473:139-147. doi: 10.1016/j.canlet.2019.12.043. Epub 2020 Jan 2.
Ovarian cancer (OC), one of the gynecologic malignancies with high invasive and metastatic potential, has a low survival rate in females. Although cytoreductive surgery combined with chemotherapy is the principal treatment for OC, the prognosis remains poor, and the recurrence rate of OC remains high. It is urgent to explore novel biomarkers for the diagnosis and prognosis of OC, as well as therapeutic targets. Circular RNAs (circRNAs) are a class of highly conserved, stable and abundant noncoding RNAs (ncRNAs). Recent studies have shown that circRNAs participate in OC progression by regulating various processes, including cell proliferation, migration, invasion and apoptosis. In addition, circRNAs are potential biomarkers for OC diagnosis and prognosis. This review provides an overview of recent findings on circRNAs in OC, including their functions and molecular mechanisms, and discusses their potential roles as diagnostic and prognostic biomarkers, as well as therapeutic targets for OC.
卵巢癌 (OC) 是一种具有高侵袭性和转移性潜能的妇科恶性肿瘤,女性患者的生存率较低。尽管细胞减灭术联合化疗是 OC 的主要治疗方法,但预后仍然较差,OC 的复发率仍然很高。因此,迫切需要探索用于 OC 诊断和预后的新型生物标志物以及治疗靶点。环状 RNA(circRNA)是一类高度保守、稳定且丰富的非编码 RNA(ncRNA)。最近的研究表明,circRNA 通过调节细胞增殖、迁移、侵袭和凋亡等多种过程参与 OC 的进展。此外,circRNA 是 OC 诊断和预后的潜在生物标志物。本综述概述了 circRNA 在 OC 中的最新研究进展,包括其功能和分子机制,并讨论了它们作为 OC 诊断和预后生物标志物以及治疗靶点的潜在作用。